• Twitter
  • Facebook
  • Linkedin
  • Mail
GVN
COVID-19 Variants and Vaccines
  • Home
  • About
    • About
    • Mission
    • Letter from the President
    • Board of Directors/Advisors
    • Scientific Advisory Board
    • Media Inquiries
    • GVN Team
    • Partners
    • Careers at GVN
  • GVN Members
    • GVN Academic Centers of Excellence & Affiliates
    • GVN Healthcare & Pharma Centers of Excellence Coalition
  • Activities
    • Research
      • GVN SARS-CoV-2 Response Effort Highlights
      • SARS-CoV-2 Task Force
      • Zika Virus Task Force
      • HTLV-1 Task Force
      • Chikungunya Task Force
      • Translational Medicine and Clinical Research
    • Training
      • 7th Annual Short Course in Basic and Translational Virology
      • Online Course on Microbiomes and their Impact on Viral Infections
      • Short Course Alumni Database
      • Hepatitis In India
    • Advocacy
      • Initiatives
      • HTLV-1 Letter
  • Publications
    • GVN Perspectives
    • GVN Weekly Brief
    • GVN Center/Member Publications
    • GVN Webinars
    • GVN 2020 End of Year Brief
    • GVN Previous Publications
    • Essays
    • Videos
  • Events
    • GVN Latin America – Caribbean Meeting 2021
    • GVN Special Annual Meeting 2020
    • GVN Meetings
    • Robert C. Gallo Award
    • Zika Virus Meeting
    • Journalist Virology Workshop
  • News
    • Press Releases
    • GVN in the News
    • Media Inquiries
    • GVN Weekly Brief
    • Join the GVN Mailing List
  • Support
  • GVN and SARS-CoV-2
    • Dr. Christian Brechot Blog
    • GVN Center & Member Spotlight
    • GVN COVID-19 Webinar Series
    • GVN SARS-CoV-2 Perspectives
    • GVN in the News
    • Saliva Testing for COVID-19
    • SARS-CoV-2 News and Updates
  • Members Login
  • Search
  • Menu

Latest News CDC says fully vaccinated Americans can spend time together indoors and unmasked - STAT, 03/08/21 More Contagious Variant Is Spreading Fast in U.S., Even as Overall Cases Level Off - NYT, 03/06/21 New data show that leading covid-19 vaccines have similarly high efficacy - The Economist, 03/06/21

  • Frequently Asked Questions
  • COVID-19 Variants
    • B1.1.7 (U.K.)
    • B1.351 (South Africa)
    • B1.1.28 (Brazil)
    • Cal.20.C (California)
    • Emerging Variants
  • COVID-19 Vaccines
    • Vaccine Overview
    • Vaccine Development & Clinical Trials
  • News & Publications

Important News and Publications

News

  • CDC says fully vaccinated Americans can spend time together indoors and unmasked
    STAT, March 8, 2021
  • More Contagious Variant Is Spreading Fast in U.S., Even as Overall Cases Level Off
    NYT, March 6, 2021
  • CDC study finds mask mandates, dining out influence virus spread
    NBC News, March 6, 2021
  • New data show that leading covid-19 vaccines have similarly high efficacy
    The Economist, March 6, 2021
  • In Oregon, Scientists Find a Virus Variant With a Worrying Mutation
    NYT, March 5, 2021
  • Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says
    Reuters, March 5, 2021
  • Brazil’s Covid Crisis Is a Warning to the Whole World, Scientists Say – The New York Times
  • March 3, 2021
  • Covid vaccines cut risk of serious illness by 80% in over-80s
    BBC, March 2, 2021
  • Merck will help make Johnson & Johnson coronavirus vaccine as rivals team up to help Biden accelerate shots
    Washington Post, March 2, 2021
  • Biden Vows Enough Vaccine ‘for Every Adult American’ by End of May
    NYT, March 2, 2021
  • Fauci says Biden administration is taking new Covid variant in New York ‘very seriously’
    CNBC, USA, March 1, 2021
  • More than 2,400 reported cases of Covid variants in the US
    CNN, March 1, 2021
  • US begins distribution of a third Covid-19 vaccine as concerns grow over latest case trends
    CNN, March 1, 2021
  • Johnson & Johnson’s Covid-19 vaccine gets the nod from CDC
    CNN, March 1, 2021
  • PM Narendra Modi gets Covid jab as India scales up vaccination
    BBC, March 1, 2021

Publications

  • What to know about J&J’s FDA-authorized one-shot COVID-19 vaccine
    Science News, February 27, 2021
  • Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
    NEJM, February 25, 2021
  • Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
    NEJM, February 25, 2021
  • Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
    Authorea, February 24, 2021
  • Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody | Science
    Science, February 19, 2021
  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine (Moderna)— Preliminary Report
  • NEJM, February 17, 2021
  • Neutralizing Activity of BNT162b2 (Pfizer)-Elicited Serum — Preliminary Report
    NEJM, February 17, 2021
  • Humoral signatures of protective and pathological SARS-CoV-2 infection in children
    Nature Medicine, February 12, 2021

Frequently Asked Questions

Contact GVN

725 West Lombard St
Room S413
Baltimore, MD 21201
(410)-706-1966

Contact Us

Support GVN

Support

The Global Virus Network is a 501(C)3.

Join Our Mailing List

Subscribe
© Copyright - GVN - Enfold Theme by Kriesi
  • Twitter
  • Facebook
  • Linkedin
  • Mail
Scroll to top